OA1-1 Impact of vorinostat treatment of non-Hodgkin‘s lymphoma on HIV-1 latent reservoir

• A. Capoferri,
• J.C. Ramos,
• Daniel Xu,
• D.I.S. Rosenbloom,
• J.D. Siliciano,
• R.F. Siliciano,
• A. Noy,
• P. Moore,
• R.F. Ambinder,
• C.M. Durand

Affiliations

A. Capoferri

Johns Hopkins University School of Medicine, Baltimore, USA

J.C. Ramos

University of Miami, Miami, USA

Daniel Xu

Johns Hopkins University School of Medicine, Baltimore, USA

D.I.S. Rosenbloom

Columbia University Medical Center, New York, USA

J.D. Siliciano

Johns Hopkins University School of Medicine, Baltimore, USA

R.F. Siliciano

Johns Hopkins University School of Medicine, Baltimore, USA

A. Noy

University of Arkansas for Medical Sciences, Little Rock, USA

P. Moore

Memorial Sloan Kettering Cancer Center, New York, USA

R.F. Ambinder

Johns Hopkins University School of Medicine, Baltimore, USA

C.M. Durand

Johns Hopkins University School of Medicine, Baltimore, USA